licaminlimab (OCS-02) - Oculis
PREDICT-1: A Clinical Study Evaluating Licaminlimab for Dry Eye Disease (clinicaltrials.gov) - Apr 24, 2026 - P2/3 | N=160 | Recruiting | Sponsor: Oculis 
New P2/3 trial • Dry Eye Disease • Ophthalmology
http://clinicaltrials.gov/ct2/show/NCT07548632
 
Apr 24, 2026
 
Prev Next